Analysis of the current situation of research and development of Scutellariae Barbatae Herba industrial chain based on patent dataZENG Ying-ying, SONG Ai-wei, LIU Yue, YUAN Hong-mei553-559
Discussion about the importance of clinical trial data disclosure in consideration of the current situation of research on PD-1/PD-L1 antibodies in ChinaLI Xin, LI Ting, SUN Fei-fei, TAO Ye, JIANG Xin, WANG Chen-jing, CAO Yu560-566
Research on risk assessment system of drug licensing transactionsCHEN Xiao-wen, WU Xia, ZHOU Bin567-571
Establishment of the first batch of national reference standard of rivaroxabanLIU Qian, FENG Yu-fei, QI Meng-jie, YANG Dong-sheng, GUAN Hao-yue, NIU Jian-zhao572-575
Study on the formulation robustness of biopharmaceutical drug products based on multivariate data analysisNIE Lei, FANG Wei-jie, GUO Ting-ting, QIAN Ci, ZHANG Yi, QU Hai-bin, WANG Hai-bin576-582
Overviews of non-clinical safety evaluation of stem cell-derived cellular therapy productsYAN Zhen-long, TENG Yi-yang, ZHANG Ya-qun, QIAN Zhuang, LI Yan-chuan, HU Wen-yuan, ZHONG Xiao-qun, HU Jing, CHEN Xiao-jun, LI Yi-hao, PENG Rui-nan, WANG Ya, LI Hui, GE Jian-ya, MIAO Cheng-xian, LV Jian-jun, OHIRA Toko583-588
Advances in multi-receptor agonists based on gastrointestinal hormones in the treatment of diabetes and obesityWANG Yuan, KANG Ming-ming, WANG Jun-jun, LI Xiao-wen, WEN Liang-zhu589-597
Research progress in application of artificial intelligence and machine learning in toxicologic pathologyLI Yi-hao, TENG Yi-yang, ZHANG Ya-qun, QIAN Zhuang, HU Wen-yuan, ZHONG Xiao-qun, HU Jing, CHEN Xiao-jun, YAN Zhen-long, PENG Rui-nan, WANG Ya, LI Hui, GE Jian-ya, MIAO Cheng-xian, SHAO Wei, LV Jian-jun, OHIRA Toko598-604
Analysis of bioequivalence studies of omeprazole enteric-coated preparations in ChinaLIU Man, LIU Hui-chen605-609
Molecular dynamics simulation study of IDH1 R132 H mutant protein and its inhibitor AG-881SHAO Ting-ting, KONG Xiao-hua, JIN Jing, MENG Fan-cui, LIU Wei610-617